PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression. (Q46614726)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617917%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617917%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617917%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Mary Ellen Moynahan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617917%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Kevin Kalinsky

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617917%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Adriana Heguy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617917%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Sujata Patil

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617917%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

English

0 references

publication date

27 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617917%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

2 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617917%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617917%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617917%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

635-643

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617917%20AND%20SRC:MED&resulttype=core&format=json

The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

PI3K pathway alterations in cancer: variations on a theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

PIK3CA mutation associates with improved outcome in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

Genomic architecture characterizes tumor progression paths and fate in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

Genetic alterations during colorectal-tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

PIK3CA mutations in in situ and invasive breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

PIK3CA mutations may be discordant between primary and corresponding metastatic disease in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

Genomic and biological characterization of exon 4 KRAS mutations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

Mammary field cancerization: molecular evidence and clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1601-4

10.1007/S10549-011-1601-4

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21617917%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference